Abstract
In research and development (R & D) sector, scientific and technical developments are ready for the expansion of oral drug delivery systems. The medicated chewing gum (MCG) takes accumulative approval as a drug delivery system in pharmaceutical as well as clinical fields. It offers advantages both for (a) local treatment and (b) systemic effect after absorption through the buccal, sublingual mucosal and from the gastrointestinal tract as comparison to conventional oral mucosal and oral dosage forms. It mainly consists of active substances and a gum core, which is mainly composed of an insoluble gum base, sweetener, antioxidants, softeners and flavouring agents. Today improved technologies have made it possible to develop and manufacture MCG with predefined properties. A large number of marketed formulations are available for prevention of caries, xerostomia alleviation, and vitamin/ mineral supplementation etc. In this review article, we discussed the unique characteristics and their applications of MCG formulation in different fields to control and treat the disease by sustained release of drug/ bioactive molecules. Finally, in upcoming years, we may realize that the MCG formulation place preference to other delivery systems to distribute the drugs locally.
Keywords: Elastomer, medicated chewing gum, patient compliance, sustained drug delivery.
Drug Delivery Letters
Title:Medicated Chewing Gum: Patient Compliance Oral Drug Delivery System
Volume: 4 Issue: 1
Author(s): Tarun Garg and Amit K. Goyal
Affiliation:
Keywords: Elastomer, medicated chewing gum, patient compliance, sustained drug delivery.
Abstract: In research and development (R & D) sector, scientific and technical developments are ready for the expansion of oral drug delivery systems. The medicated chewing gum (MCG) takes accumulative approval as a drug delivery system in pharmaceutical as well as clinical fields. It offers advantages both for (a) local treatment and (b) systemic effect after absorption through the buccal, sublingual mucosal and from the gastrointestinal tract as comparison to conventional oral mucosal and oral dosage forms. It mainly consists of active substances and a gum core, which is mainly composed of an insoluble gum base, sweetener, antioxidants, softeners and flavouring agents. Today improved technologies have made it possible to develop and manufacture MCG with predefined properties. A large number of marketed formulations are available for prevention of caries, xerostomia alleviation, and vitamin/ mineral supplementation etc. In this review article, we discussed the unique characteristics and their applications of MCG formulation in different fields to control and treat the disease by sustained release of drug/ bioactive molecules. Finally, in upcoming years, we may realize that the MCG formulation place preference to other delivery systems to distribute the drugs locally.
Export Options
About this article
Cite this article as:
Garg Tarun and K. Goyal Amit, Medicated Chewing Gum: Patient Compliance Oral Drug Delivery System, Drug Delivery Letters 2014; 4 (1) . https://dx.doi.org/10.2174/2210303103999131211110414
DOI https://dx.doi.org/10.2174/2210303103999131211110414 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Platelets and Platelet Interaction with Progenitor Cells in Vascular Homeostasis and Inflammation
Current Vascular Pharmacology Piperidin-4-one: The Potential Pharmacophore
Mini-Reviews in Medicinal Chemistry Animal Models of Diabetes Mellitus: Relevance to Vascular Complications
Current Pharmaceutical Design Proteomics and Mass Spectrometry: What Have We Learned About The Heart?
Current Cardiology Reviews The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology
Current Topics in Medicinal Chemistry Inhibition of Matrix Metalloproteinases (MMPs) as a Potential Strategy to Ameliorate Hypertension-Induced Cardiovascular Alterations
Current Drug Targets Efforts to Understand the Molecular Basis of Hypertension Through Drug:Membrane Interactions
Current Topics in Medicinal Chemistry Nutrition and Growth in Children with Chronic Liver Disease and After Liver Transplantation
Current Nutrition & Food Science Pharmaceutical Cocrystal: A Novel Approach to Tailor the Biopharmaceutical Properties of a Poorly Water Soluble Drug
Recent Patents on Drug Delivery & Formulation Thrombolysis for Acute Ischemic Stroke
Current Topics in Medicinal Chemistry Current Concepts in SLE Thrombocytopenia: From Pathophysiology to Therapeutic Interventions
Current Rheumatology Reviews Engagement of Renin-Angiotensin System in Prostate Cancer
Current Cancer Drug Targets Vasopressin Receptor Antagonists in Heart Failure
Recent Patents on Cardiovascular Drug Discovery Enzyme Inhibition by Peroxynitrite-Mediated Tyrosine Nitration and Thiol Oxidation
Current Enzyme Inhibition Editorial (Thematic Issue: Molecular Basis of Gastrointestinal Chemical Senses)
Current Pharmaceutical Design Sleep-Disordered Breathing and Cardiovascular Disease: Exploring Pathophysiology and Existing Data
Current Respiratory Medicine Reviews Meet Our Editorial Board Member
Current Vascular Pharmacology A Murine Model of Vasculitis Induced by Fungal Polysaccharide
Cardiovascular & Hematological Agents in Medicinal Chemistry Markers of Arrhythmogenic Risk in Hypertensive Subjects
Current Pharmaceutical Design Update on the Therapies of Severe Lupus Nephritis
Current Rheumatology Reviews